Riskpilot← Back to searchSign inGet full accessWeiting Li AB
ABActiveOrg 5568824071Cardellsgatan 19Hospital activities · NACE 8610Est. 20120 employees
Revenue 2024
SEK 333K
-53% vs 2023
EBITDA margin
67.9%
-63% vs 2023
Equity ratio
87.0%
Financial strength
Net profit 2024
SEK 322K
-5% vs 2023
| Revenue | SEK 333K | -53% |
| EBITDA | SEK 226K | -63% |
| Net profit | SEK 322K | -5% |
| Total assets | SEK 494K | -41% |
| Equity | SEK 430K | -28% |
| Employees | 0 | — |
Legal name
Weiting Li AB
Org number
5568824071
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva äga aktier och andelar i andra företag, kroppsvård med speciell inriktning mot traditionell kinesisk medicin, personaluthyrning,specialiserad sluten psykiatrisk hälso- och sjukvård på sjukhus och öppenvård
Address
Cardellsgatan 19
Phone
+46760444891
Email
weitingliab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 59 | 81 | 439 | 715 | 333 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −50 | 17 | 242 | 609 | 226 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −50 | 17 | 242 | 609 | 226 |
| Net financials | — | — | — | — | — |
| Profit before tax | −50 | 17 | 11 | 428 | 406 |
| Tax | −0 | −0 | −2 | −88 | −84 |
| Net profit | −50 | 17 | 9 | 340 | 322 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 222 | 146 | 283 | 837 | 494 |
| Equity | 8 | 26 | 267 | 596 | 430 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 214 | 120 | 16 | 60 | 64 |
| Total debt | 214 | 120 | 16 | 60 | 64 |
EBITDA margin
67.9%
This company
15.8%
Market median
+330% vs market
20202024
Equity ratio
87.0%
This company
38.2%
Market median
+128% vs market
20202024
Return on equity
74.9%
This company
18.4%
Market median
+307% vs market
20202024
Net profit margin
96.7%
This company
8.1%
Market median
+1094% vs market
20202024
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WL Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2023 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Weiting Li AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Weiting Li | Chief Executive Officer | 0 companies |
| Erik Hans Ludvig Havelius | Deputy Board Member | 0 companies |
| Gustav Janusz Wik | Deputy Board Member | 0 companies |
| Chen-Ying Hsu | Deputy Board Member | 0 companies |